These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25962056)

  • 21. Transdermal androgens: pharmacology and applicability to hypogonadal elderly men.
    Swerdloff RS; Wang C
    J Endocrinol Invest; 2005; 28(3 Suppl):112-6. PubMed ID: 16042369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of adverse outcomes in women using testosterone therapy.
    van Staa TP; Sprafka JM
    Maturitas; 2009 Jan; 62(1):76-80. PubMed ID: 19108962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial.
    Spitzer M; Basaria S; Travison TG; Davda MN; Paley A; Cohen B; Mazer NA; Knapp PE; Hanka S; Lakshman KM; Ulloor J; Zhang A; Orwoll K; Eder R; Collins L; Mohammed N; Rosen RC; DeRogatis L; Bhasin S
    Ann Intern Med; 2012 Nov; 157(10):681-91. PubMed ID: 23165659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfer of transdermally applied testosterone to clothing: a comparison of a testosterone patch versus a testosterone gel.
    Mazer N; Fisher D; Fischer J; Cosgrove M; Bell D; Eilers B
    J Sex Med; 2005 Mar; 2(2):227-34. PubMed ID: 16422890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reproductive endocrinology: Are intramuscular testosterone injections harmful?
    Anawalt BD; Bremner WJ
    Nat Rev Endocrinol; 2015 Sep; 11(9):510-1. PubMed ID: 26149613
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.
    Swerdloff RS; Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Longstreth J; Berman N
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4500-10. PubMed ID: 11134099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.
    Haddad RM; Kennedy CC; Caples SM; Tracz MJ; Boloña ER; Sideras K; Uraga MV; Erwin PJ; Montori VM
    Mayo Clin Proc; 2007 Jan; 82(1):29-39. PubMed ID: 17285783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.
    Caanen MR; Schouten NE; Kuijper EAM; van Rijswijk J; van den Berg MH; van Dulmen-den Broeder E; Overbeek A; van Leeuwen FE; van Trotsenburg M; Lambalk CB
    Hum Reprod; 2017 Jul; 32(7):1457-1464. PubMed ID: 28505246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone therapy--what, when and to whom?
    Jockenhövel F
    Aging Male; 2004 Dec; 7(4):319-24. PubMed ID: 15799128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone patches for female sexual dysfunction.
    Drug Ther Bull; 2009 Mar; 47(3):30-4. PubMed ID: 19261838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testosterone Therapy and Risk of Acute Myocardial Infarction in Hypogonadal Men: An Administrative Health Care Claims Study.
    Li H; Mitchell L; Zhang X; Heiselman D; Motsko S
    J Sex Med; 2017 Nov; 14(11):1307-1317. PubMed ID: 29110802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.
    Achilli C; Pundir J; Ramanathan P; Sabatini L; Hamoda H; Panay N
    Fertil Steril; 2017 Feb; 107(2):475-482.e15. PubMed ID: 27916205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Testosterone Treatment and Risk of Incident Cardiovascular Events Among US Male Veterans With Low Testosterone Levels and Multiple Medical Comorbidities.
    Shores MM; Walsh TJ; Korpak A; Krakauer C; Forsberg CW; Fox AE; Moore KP; Heckbert SR; Thompson ML; Smith NL; Matsumoto AM
    J Am Heart Assoc; 2021 Sep; 10(17):e020562. PubMed ID: 34423650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Mortality and Major Cardiovascular Events Among Adults With Type 2 Diabetes Using Human vs Analogue Insulins.
    Neugebauer R; Schroeder EB; Reynolds K; Schmittdiel JA; Loes L; Dyer W; Desai JR; Vazquez-Benitez G; Ho PM; Anderson JP; Pimentel N; O'Connor PJ
    JAMA Netw Open; 2020 Jan; 3(1):e1918554. PubMed ID: 31977057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse events associated with testosterone administration.
    Basaria S; Coviello AD; Travison TG; Storer TW; Farwell WR; Jette AM; Eder R; Tennstedt S; Ulloor J; Zhang A; Choong K; Lakshman KM; Mazer NA; Miciek R; Krasnoff J; Elmi A; Knapp PE; Brooks B; Appleman E; Aggarwal S; Bhasin G; Hede-Brierley L; Bhatia A; Collins L; LeBrasseur N; Fiore LD; Bhasin S
    N Engl J Med; 2010 Jul; 363(2):109-22. PubMed ID: 20592293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone 2% gel can normalize testosterone concentrations in men with low testosterone regardless of body mass index.
    Dobs A; Norwood P; Potts S; Gould E; Chitra S
    J Sex Med; 2014 Mar; 11(3):857-64. PubMed ID: 24283410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study.
    Zhang M; Solomon DH; Desai RJ; Kang EH; Liu J; Neogi T; Kim SC
    Circulation; 2018 Sep; 138(11):1116-1126. PubMed ID: 29899013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment.
    Wallach JD; Deng Y; McCoy RG; Dhruva SS; Herrin J; Berkowitz A; Polley EC; Quinto K; Gandotra C; Crown W; Noseworthy P; Yao X; Shah ND; Ross JS; Lyon TD
    JAMA Netw Open; 2021 Oct; 4(10):e2130587. PubMed ID: 34677594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment options for a patient experiencing pruritic rash associated with transdermal testosterone: a review of the literature.
    McGriff NJ; Csako G; Kabbani M; Diep L; Chrousos GP; Pucino F
    Pharmacotherapy; 2001 Nov; 21(11):1425-35. PubMed ID: 11714217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study.
    Loo SY; Azoulay L; Nie R; Dell'Aniello S; Yu OHY; Renoux C
    Am J Med; 2019 Sep; 132(9):1069-1077.e4. PubMed ID: 30953635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.